Cite

HARVARD Citation

    McClurg, U. et al. (n.d.). A novel anti-androgen candidate galeterone acts by targeting USP12, a deubiquitinating enzyme that controls prostate cancer growth and survival. European journal of cancer. pp. S25-. [Online]. 
  
Back to record